AstraZeneca begins preliminary of antibody treatment for COVID-19

AstraZeneca begins preliminary of antibody treatment for COVID-19

Overview

  • Post By : Kumar Jeetendra

  • Source: Reuters

  • Date: 25 Aug,2020

AstraZeneca said on Tuesday it began early stage trials to get an antibody-based treatment for the prevention and treatment of COVID-19, as the British drugmaker also ploughs on with its vaccine candidate.

The trial will assess if AZD7442, a blend of two monoclonal antibodies, is tolerable and safe in up to 48 healthy participants between the ages of 18 and 55 years in the uk together with the backing of the USA.

About Author